FDA ups warning on NSAIDs for heart, stroke risks

The FDA is now requiring a stronger warning on over-the-counter NSAIDs (non-steroidal anti-inflammatory drugs) to inform users of the increased risk of stroke and heart complications. There is increasing evidence that this family of medications greatly increases risk, especially in patients who already have identifiable stoke, high blood pressure, and other heart-associated illness. Adding a question to your intake forms for NSAID use and associated risk disease states can protect patients.